Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| GeneDx Holdings Corporation | WGS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 0.3836 | 04:20:17 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.3836 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.272 - 0.5427 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.3836 | USD |
GeneDx Holdings Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 306.21M | 798.25M | 668.67M | $ 234.69M | $ -210.85M | -1.64 | 1.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 218.40M | 0.20% |
GeneDx News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical WGS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.333 | 0.52 | 0.32 | 0.3811603 | 10,110,528 | 0.0506 | 15.2% |
| 1 Month | 0.4725 | 0.53 | 0.272 | 0.4082203 | 5,643,180 | -0.0889 | -18.81% |
| 3 Months | 0.331 | 0.5427 | 0.272 | 0.4220093 | 4,664,572 | 0.0526 | 15.89% |
| 6 Months | 0.331 | 0.5427 | 0.272 | 0.4220093 | 4,664,572 | 0.0526 | 15.89% |
| 1 Year | 0.331 | 0.5427 | 0.272 | 0.4220093 | 4,664,572 | 0.0526 | 15.89% |
| 3 Years | 0.331 | 0.5427 | 0.272 | 0.4220093 | 4,664,572 | 0.0526 | 15.89% |
| 5 Years | 0.331 | 0.5427 | 0.272 | 0.4220093 | 4,664,572 | 0.0526 | 15.89% |
GeneDx Description
| GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by one of the world's largest rare disease data sets. It has two segments GeneDx and Legacy Sema4 diagnostics. |